Dharti Proteins Limited has officially communicated to the Bombay Stock Exchange that it does not fall under the Large Corporate framework as defined by the Securities and Exchange Board of India. The declaration, submitted on April 13, 2026, clarifies the company's regulatory compliance status regarding debt securities disclosure requirements.

Regulatory Framework Declaration

The company's declaration references specific SEBI circulars SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023. These circulars establish the framework for fund raising through debt securities issuance by Large Corporates and mandate specific disclosure compliance requirements.

Compliance Implications

The non-applicability of the Large Corporate framework means Dharti Proteins Limited is exempt from filing the Initial Disclosure in Annexure "A" as required under BSE circulars for the year ended March 31, 2026. This exemption is based on the company not meeting the applicability criteria outlined in the SEBI operational circular dated August 10, 2021.

Company Profile

Dharti Proteins Limited operates from its registered office at A-1115, Titanium Business Park, Near Makarba Underpass, Makarba, Ahmedabad. The company's declaration was signed by Twinkle Bipinchandra Gajjar, Company Secretary and Compliance Officer, and Sohan Lal, Chief Financial Officer, confirming the accuracy of the submitted information.

The formal declaration ensures regulatory clarity and maintains the company's compliance status with stock exchange requirements while confirming its position outside the Large Corporate regulatory framework.

Dharti Proteins Limited (formerly Devika Proteins Limited) has filed its quarterly compliance certificate with BSE Limited for the quarter ended March 31, 2026. The submission fulfills mandatory requirements under SEBI's depository regulations for listed companies.

Regulatory Compliance Filing

The company submitted its certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018 on April 7, 2026. Company Secretary and Compliance Officer Twinkle Bipinchandra Gajjar signed the filing on behalf of Dharti Proteins Limited.

RTA Confirmation Certificate

System Support Services, serving as the company's Registrar and Share Transfer Agent, issued the confirmation certificate on April 2, 2026. The RTA confirmed that securities received from depository participants for dematerialization during Q4FY26 were properly processed according to regulatory requirements.

The certificate validates that:

• Securities received for dematerialization were confirmed to depositories
• Security certificates were mutilated and cancelled after verification
• Depository names were substituted in the register of members within the prescribed 30-day period
• All securities remain listed on stock exchanges where previously issued securities are traded

Company Information

Dharti Proteins Limited operates from its registered office at A-1115, Titanium Business Park, Near Makarba Underpass, Makarba, Ahmedabad. The company maintains its compliance obligations through regular filings with stock exchanges and regulatory authorities.

This quarterly certificate submission represents standard regulatory compliance for listed companies, ensuring transparency in securities handling and depository operations. The filing confirms the company's adherence to SEBI's framework governing depository participants and securities dematerialization processes.